Anterior Glenohumeral Dislocations
Conditions
Brief summary
The glenohumeral joint has the highest rate of dislocation of the whole body, due to its high mobility and the special characteristics of its anatomy. It is estimated that every year between 1-2% of the population will suffer from glenohumeral dislocation. The vast majority of studies are based on young patients under the age of 40, given that at this age they have the higher incidence and at the same time, they have higher redislocation index. However, the investigators are in front of a more active population with a longer life expectancy. That is why the cases of anterior glenohumeral dislocations are increasing in people older than 40 years. Given that most studies focus on younger patients, the investigators lack knowledge about which injuries are associated with dislocation at this age and whether these influence its clinical evolution.
Interventions
PROCEDUREReduction
An Rx will be performed before and after the reduction of the dislocation. After that, the neurovascular state will be checked and also if there is some associated injury.
Sponsors
Corporacion Parc Tauli
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
40 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* More than 40 years old * First episode of traumatic anterior gelnohumeral dislocation seen in Rx * Acceptance to be checked over 2 years * Acceptance to be submitted to TAC, NMR, EMG and Bilateral Ultrasound
Exclusion criteria
* Previous fractures in this extremity * Previous neurovascular lesions in this extremity * Other associated lesions * Cognitive alterations or dementia which prevent completing the protocols. Patients with \<14 points in Mini-mental test.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Characterization of associated lesions | At the three months visit including assessment of NMR/EMG/TAC/Bilateral Ultrasound |
Secondary
| Measure | Time frame |
|---|---|
| Constant Functional Test | 3, 6, 12 and 24 months |
| WOSI test | 3, 6, 12 and 24 months |
| SST | 3, 6, 12 and 24 months |
| Redislocations | 3, 6, 12 and 24 months |
| Type of treatment | 3, 6, 12 and 24 months |
Countries
Spain
Contacts
Primary ContactMònica Salomó
Backup ContactMireia Viñas
Outcome results
None listed